[
  {
    "ts": null,
    "headline": "J&J Sues U.S. Over Hospital Drug-Discounting Program",
    "summary": "The company filed a lawsuit asking for a federal court’s permission to change when it gives lucrative drug discounts to hospitals.",
    "url": "https://finnhub.io/api/news?id=0cb1258701ced78d6788cd75ceacc966d7ff4df57d0c2a88e31c3c750e717f61",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731441840,
      "headline": "J&J Sues U.S. Over Hospital Drug-Discounting Program",
      "id": 131317292,
      "image": "https://s.yimg.com/ny/api/res/1.2/ZJpneWXQaS1T93mwSW9dvw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/3c4a2ba1b08977259f327d839b4f87c1",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The company filed a lawsuit asking for a federal court’s permission to change when it gives lucrative drug discounts to hospitals.",
      "url": "https://finnhub.io/api/news?id=0cb1258701ced78d6788cd75ceacc966d7ff4df57d0c2a88e31c3c750e717f61"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson stock underperforms Tuesday when compared to competitors",
    "summary": "Johnson & Johnson stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=593236082f5607659a0189251b7f39dbe13e27455de20162b04c35b60ee11063",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731429060,
      "headline": "Johnson & Johnson stock underperforms Tuesday when compared to competitors",
      "id": 131413912,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=593236082f5607659a0189251b7f39dbe13e27455de20162b04c35b60ee11063"
    }
  },
  {
    "ts": null,
    "headline": "J&J’s Ottava surgical robot to begin clinical trial after FDA nod",
    "summary": "With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging Intuitive Surgical’s da Vinci system.",
    "url": "https://finnhub.io/api/news?id=e3120ab605321948d89150588fe314631bb2776f7c50ec42da20313f8c2b176e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731411603,
      "headline": "J&J’s Ottava surgical robot to begin clinical trial after FDA nod",
      "id": 131308940,
      "image": "https://imgproxy.divecdn.com/jLIRhZOD0ebXKlBfRX-1EzJzgCZ_IBqoxCjfZgKFp08/g:ce/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0pKX0xvYmJ5MDFfSGlnaFJlc19DOVd1OXBMLmpwZw==.webp",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging Intuitive Surgical’s da Vinci system.",
      "url": "https://finnhub.io/api/news?id=e3120ab605321948d89150588fe314631bb2776f7c50ec42da20313f8c2b176e"
    }
  },
  {
    "ts": null,
    "headline": "3M, Boeing share losses contribute to Dow's 234-point drop",
    "summary": "3M, Boeing share losses contribute to Dow's 234-point drop",
    "url": "https://finnhub.io/api/news?id=5e51c72a20faeaa70ed7937dbabb48a8b0c662d1149c0eb695fc793e84e3d034",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731411540,
      "headline": "3M, Boeing share losses contribute to Dow's 234-point drop",
      "id": 131413577,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "3M, Boeing share losses contribute to Dow's 234-point drop",
      "url": "https://finnhub.io/api/news?id=5e51c72a20faeaa70ed7937dbabb48a8b0c662d1149c0eb695fc793e84e3d034"
    }
  },
  {
    "ts": null,
    "headline": "3M, UnitedHealth share losses lead Dow's 115-point drop",
    "summary": "3M, UnitedHealth share losses lead Dow's 115-point drop",
    "url": "https://finnhub.io/api/news?id=7a684154148ebe0befd419daa402ea6f9590f2f9f69115b0afe4f6587f1b4678",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731407280,
      "headline": "3M, UnitedHealth share losses lead Dow's 115-point drop",
      "id": 131413579,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "3M, UnitedHealth share losses lead Dow's 115-point drop",
      "url": "https://finnhub.io/api/news?id=7a684154148ebe0befd419daa402ea6f9590f2f9f69115b0afe4f6587f1b4678"
    }
  },
  {
    "ts": null,
    "headline": "J&J: 'Breakthrough Therapy' from the FDA for nipocalimab",
    "summary": "Johnson & Johnson announces that the FDA has granted nipocalimab Breakthrough Therapy designation for the treatment of adults with moderate to severe Sjögren's disease. Nipocalimab is the first...",
    "url": "https://finnhub.io/api/news?id=8a37e10de37f40386fa9e85d614dd04ffcce11b56de1422053bd7042ed23207e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731406809,
      "headline": "J&J: 'Breakthrough Therapy' from the FDA for nipocalimab",
      "id": 131305371,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson announces that the FDA has granted nipocalimab Breakthrough Therapy designation for the treatment of adults with moderate to severe Sjögren's disease. Nipocalimab is the first...",
      "url": "https://finnhub.io/api/news?id=8a37e10de37f40386fa9e85d614dd04ffcce11b56de1422053bd7042ed23207e"
    }
  },
  {
    "ts": null,
    "headline": "J&J: FDA green light for robotic system trial",
    "summary": "Johnson & Johnson MedTech has announced that the FDA has approved the Investigational Device Exemption for its OTTAVA robotic surgical system, thereby authorizing the launch of clinical trials in the...",
    "url": "https://finnhub.io/api/news?id=cc65bc7cdd6a13cdad8a17e6208665c3bb288885d3afc670114a94412399060d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731405854,
      "headline": "J&J: FDA green light for robotic system trial",
      "id": 131305213,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson MedTech has announced that the FDA has approved the Investigational Device Exemption for its OTTAVA robotic surgical system, thereby authorizing the launch of clinical trials in the...",
      "url": "https://finnhub.io/api/news?id=cc65bc7cdd6a13cdad8a17e6208665c3bb288885d3afc670114a94412399060d"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson - Nipocalimab is the first and only investigational therapy granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjogren's disease",
    "summary": "Spring House - Johnson & Johnson today announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the treatment of adults living with...",
    "url": "https://finnhub.io/api/news?id=531b04c7e182c3d6c262c5ce823e3c8a15a86fc08189ced94bbf491df62139ef",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731403418,
      "headline": "Johnson & Johnson - Nipocalimab is the first and only investigational therapy granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjogren's disease",
      "id": 131304765,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Spring House - Johnson & Johnson today announced that the U.S. Food and Drug Administration has granted nipocalimab Breakthrough Therapy designation for the treatment of adults living with...",
      "url": "https://finnhub.io/api/news?id=531b04c7e182c3d6c262c5ce823e3c8a15a86fc08189ced94bbf491df62139ef"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson : MedTech Receives IDE Approval for OTTAVA™ Robotic Surgical System",
    "summary": "New Brunswick, NJ - November 12, 2024 - Johnson & Johnson MedTech, a global leader in cardiovascular, orthopaedic, surgery and vision solutions, today announced that the U.S. Food & Drug...",
    "url": "https://finnhub.io/api/news?id=a80be0478fda8cc6b1b0b4224d3b10e5b0595bd1879bbe80e23e1201865b7c90",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731399431,
      "headline": "Johnson & Johnson : MedTech Receives IDE Approval for OTTAVA™ Robotic Surgical System",
      "id": 131303790,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "New Brunswick, NJ - November 12, 2024 - Johnson & Johnson MedTech, a global leader in cardiovascular, orthopaedic, surgery and vision solutions, today announced that the U.S. Food & Drug...",
      "url": "https://finnhub.io/api/news?id=a80be0478fda8cc6b1b0b4224d3b10e5b0595bd1879bbe80e23e1201865b7c90"
    }
  }
]